Rebecca Jung
Mainz, RP 55131, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Antagonizing IL-17A Reduces Vascular Inflammation and Attenuates Oxidative Stress Formation but Does Not Significantly Improve Vascular Dysfunction Induced by One Week of Angiotensin II Treatment.
Journal: Antioxidants (Basel, Switzerland)
Published: December 13, 2025
Myeloid cell-derived interleukin-6 induces vascular dysfunction and vascular and systemic inflammation.
Journal: European heart journal open
Published: December 11, 2022
Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriatic skin inflammation.
Journal: Cell reports
Published: January 25, 2022
Targeting myeloid cell coagulation signaling blocks MAP kinase/TGF-β1-driven fibrotic remodeling in ischemic heart failure.
Journal: The Journal of clinical investigation
Published: November 04, 2021
B Lymphocyte-Deficiency in Mice Causes Vascular Dysfunction by Inducing Neutrophilia.
Journal: Biomedicines
Published: August 21, 2021
Aestivation motifs explain hypertension and muscle mass loss in mice with psoriatic skin barrier defect.
Journal: Acta physiologica (Oxford, England)
Published: December 19, 2020
Skin Sodium Accumulates in Psoriasis and Reflects Disease Severity.
Journal: The Journal of investigative dermatology
Published: September 04, 2020
Tubulin-folding cofactor E deficiency promotes vascular dysfunction by increased endoplasmic reticulum stress.
Journal: European heart journal
Published: July 19, 2020
Innate Immune Mechanisms of Arterial Hypertension and Autoimmune Disease.
Journal: American journal of hypertension
Published: June 15, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026